Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Wellstar International, Inc. (WLSI)
Holland, OH, US
Wellstar International, Inc. currently engages in very limited business activities. In its past operations, the company, through its subsidiary, Trillennium Medical Imaging, Inc., concentrated on creating and licensing advanced thermal imaging solutions for various consumer healthcare needs. This sophisticated technology provided diagnostic screening for the early detection of breast cancer. Additionally, it assisted in distinguishing between different pain conditions, including reflex sympathetic dystrophy, neuromusculoskeletal syndromes, and other neurological disorders. The technology was also utilized for identifying pressure ulcers, deep tissue damage, and bedsores, alongside its uses in orthopedic applications. Founded in 1997, Wellstar International, Inc. is headquartered in Holland, Ohio.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -90.00% | -90.00% | -99.00% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Devices: +11.2%—
-
EPS growth Medical - Devices: +28.5%+98.6% ★ Q4'10: -106.2% (vs Q4'09)
-
FCF margin FCF growth · Medical - Devices: +30.9%—
-
EBIT margin Medical - Devices: +6.2%—
-
ROIC Medical - Devices: +3.3%— Q4'10: +45.7% (vs Q4'09)
-
Share dilution Medical - Devices: 0.0%+422.5% Q4'10: +602.8% (vs Q4'09)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-37.87× Q4'10: -42.69× (vs Q4'09)
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| John Antonio | Chairman, Chief Executive Officer & President | 240.0K | male |
| Kenneth McCoppen | Senior Vice President & Director | 201.6K | male |
| Howard Bielski | Chief Financial Officer, Principal Accounting Officer, Secretary & Controller | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for WLSI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
